In March 2025, the company declared new strategies for your immediate-to-consumer supplying of its Wegovy weight loss drug. The company recognized a completely new pharmacy, identified as NovoCare, which might cost shoppers $499 per 30 days for use of the drug, below 50 percent the expense of the drug via other pharmaceutical distribution networks.